NCT02925351View on ClinicalTrials.gov

Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 25, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Autoimmune DiseaseCrohn DiseaseInflammatory DisorderRheumatoid ArthritisSystemic Lupus ErythematosusTakayasu Arteritis
Interventions
PROCEDURE

Computed Tomography

Undergo PET/CT scan

RADIATION

Fluorine F 18 Clofarabine

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT scan

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

Jonsson Comprehensive Cancer Center

OTHER

NCT02925351 - Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases | Biotech Hunter | Biotech Hunter